Organon & Co | OGN - 贸易债权人





贸易债权人 更改 日
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Celltrion KRW 88.58B 9.9B 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Gilead Sciences USD 645M 70M 2026-03
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 3.83B 36M 2026-06
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.32B 134M 2026-03
Organigram Holdings CAD 73.14M 2.06M 2026-03
Organon & Co USD 1.05B 68M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pharma Mar EUR 38.93M 4.9M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 171M 175.6M 2026-03